Abstract:The estimands framework outlined in ICH E9 (R1) describes the components needed to precisely define the effects to be estimated in clinical trials, which includes how post-baseline "intercurrent" events (IEs) are to be handled. In late-stage clinical trials, it is common to handle intercurrent events like "treatment discontinuation" using the treatment policy strategy and target the treatment effect on all outcomes regardless of treatment discontinuation. For continuous repeated measures, this type of effect is often estimated using all observed data before and after discontinuation using either a mixed model for repeated measures (MMRM) or multiple imputation (MI) to handle any missing data. In basic form, both of these estimation methods ignore treatment discontinuation in the analysis and therefore may be biased if there are differences in patient outcomes after treatment discontinuation compared to patients still assigned to treatment, and missing data being more common for patients who have discontinued treatment. We therefore propose and evaluate a set of MI models that can accommodate differences between outcomes before and after treatment discontinuation. The models are evaluated in the context of planning a phase 3 trial for a respiratory disease. We show that analyses ignoring treatment discontinuation can introduce substantial bias and can sometimes underestimate variability. We also show that some of the MI models proposed can successfully correct the bias but inevitably lead to increases in variance. We conclude that some of the proposed MI models are preferable to the traditional analysis ignoring treatment discontinuation, but the precise choice of MI model will likely depend on the trial design, disease of interest and amount of observed and missing data following treatment discontinuation.

A Causal Mediation Approach to Account for Interaction of Treatment and Intercurrent Events: Using Hypothetical Strategy

Estimating hypothetical estimands with causal inference and missing data estimators in a diabetes trial

Defining estimands using a mix of strategies to handle intercurrent events in clinical trials

Nonparametric estimators of interventional (transported) direct and indirect effects that accommodate multiple mediators and multiple intermediate confounders

Post-Treatment Confounding in Causal Mediation Studies: A Cutting-Edge Problem and A Novel Solution via Sensitivity Analysis

Translating questions to estimands in randomized clinical trials with intercurrent events

Application of hypothetical strategies in acute pain

Estimating Time-Varying Direct and Indirect Causal Excursion Effects with Longitudinal Binary Outcomes

Estimation methods for estimands using the treatment policy strategy; a simulation study based on the PIONEER 1 Trial

Implementation of tripartite estimands using adherence causal estimators under the causal inference framework

Estimating treatment effect in randomized trial after control to treatment crossover using external controls

Identifiability and Estimation of Causal Mediation Effects with Missing Data

Conditional and Unconditional Treatment Effects in Randomized Clinical Trials: Estimands, Estimation, and Interpretation

Estimands in clinical trials of complex disease processes

Estimation of treatment policy estimands for continuous outcomes using off treatment sequential multiple imputation

Multiply robust estimators in longitudinal studies with missing data under control-based imputation

Applying the estimands framework to non-inferiority trials: guidance on choice of hypothetical estimands for non-adherence and comparison of estimation methods

Nonparametric Estimation of Mediation Effects with A General Treatment

Are causal effect estimations enough for optimal recommendations under multitreatment scenarios?

Statistical methods for handling missing data to align with treatment policy strategy